Forefront RF makes leadership changes for next stage of global growth

13 Aug

Written By Alexandra Collingbourne

Alexandra Collingbourne

Monument Therapeutics to trial schizophrenia therapy in partnership with FNIH

Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion